Lataa...
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
miRs play a critical role in tumor pathogenesis as either oncogenes or tumor-suppressor genes. However, the role of miRs and their regulation in response to proteasome inhibitors in multiple myeloma (MM) is unclear. In the current study, miR profiling in proteasome inhibitor MLN2238-treated MM.1S MM...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3496955/ https://ncbi.nlm.nih.gov/pubmed/22983447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-401794 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|